On June 10, 2025, Anavex Life Sciences Corp. held its Annual Meeting where stockholders approved an amendment to increase shares by 4 million and set new vesting rules for the 2022 Incentive Plan. Approximately 60.8% of shares voted, electing six new board members and ratifying Grant Thornton LLP as the independent auditor.